Table 3 Partial volumes and partial functional measurements
From: Le Cœur en Sabot: shape associations with adverse events in repaired tetralogy of Fallot
All patients (n = 192) | Adverse outcome (n = 16) | No adverse outcome (n = 176) | |
|---|---|---|---|
RV ED IPVI [ml/m2] | 59.3 ± 15.7 | 64.7 ± 13.0 | 58.7 ± 15.7 |
RV ES IPVI [ml/m2] | 36.9 ± 12.2 | 42.9 ± 10.9 | 36.5 ± 12.6* |
RV ED OPVI [ml/m2] | 25.7 ± 10.0 | 25.0 ± 10.6 | 25.7 ± 9.9 |
RV ES OPVI [ml/m2] | 18.2 ± 7.4 | 18.6 ± 8.6 | 18.1 ± 7.3 |
RV ED APVI [ml/m2] | 46.3 ± 12.5 | 48.7 ± 11.3 | 46.1 ± 12.6 |
RV ES APVI [ml/m2] | 28.6 ± 8.9 | 33.0 ± 8.4 | 28.3 ± 9.0* |
RV IPSVI [ml/m2] | 22.4 ± 7.2 | 21.8 ± 5.5 | 22.2 ± 7.8 |
RV OPSVI [ml/m2] | 7.5 ± 5.0 | 6.4 ± 5.2 | 7.6 ± 5.1 |
RV APSVI [ml/m2] | 17.7 ± 6.5 | 15.7 ± 6.3 | 17.8 ± 6.5 |
RV IPEF [%] | 38 ± 9 | 34 ± 7 | 38 ± 9* |
RV OPEF [%] | 28 ± 15 | 24 ± 16 | 28 ± 16 |
RV APEF [%] | 38 ± 10 | 32 ± 11 | 39 ± 10* |